US pharma giant Pfizer won a bidding war to acquire obesity drug developer Metsera, beating back an offer from Danish rival Novo Nordisk. The $10 billion deal — a valuation much higher than Pfizer had originally offered — followed a corporate tiff in which Novo Nordisk tried to hijack… This story appeared on semafor.com , 2025-11-09 22:35:52.
Author: semafor.com
Published at: 2025-11-09 22:59:58
Still want to read the full version? Full article
